Comparison of LCBDE vs ERCP + LC for Choledocholithiasis
A Long Term Comparison of Laparoscopic Common Bile Duct Exploration and Cholecystectomy Versus Sequential ERCP Followed by Cholecystectomy for Choledocholithiasis: a Multicenter Prospected Non-randomized Controlled Study
Sponsor: Hepatopancreatobiliary Surgery Institute of Gansu Province
A NA clinical study on Choledocholithiasis, this trial is completed. The trial is conducted by Hepatopancreatobiliary Surgery Institute of Gansu Province and has accumulated 14 data snapshots since 2015. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
14 versions recorded-
Sep 2025 — Present [monthly]
Completed NA
-
Sep 2024 — Sep 2025 [monthly]
Completed NA
-
Jul 2024 — Sep 2024 [monthly]
Completed NA
-
Feb 2024 — Jul 2024 [monthly]
Completed NA
Status: Recruiting → Completed
-
Oct 2023 — Feb 2024 [monthly]
Recruiting NA
▶ Show 9 earlier versions
-
May 2023 — Oct 2023 [monthly]
Recruiting NA
-
May 2022 — May 2023 [monthly]
Recruiting NA
-
Mar 2021 — May 2022 [monthly]
Recruiting NA
-
Jan 2021 — Mar 2021 [monthly]
Recruiting NA
-
Feb 2020 — Jan 2021 [monthly]
Recruiting NA
-
Apr 2019 — Feb 2020 [monthly]
Recruiting NA
-
Jun 2018 — Apr 2019 [monthly]
Recruiting NA
-
Feb 2017 — Jun 2018 [monthly]
Recruiting NA
-
Jan 2017 — Feb 2017 [monthly]
Recruiting NA
First recorded
Sep 2015
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Hepatopancreatobiliary Surgery Institute of Gansu Province
For direct contact, visit the study record on ClinicalTrials.gov .
Study Locations
Changchun, China , Changsha, China , Chongqing, China , Hangzhou, China , Jinan, China , Lanzhou, China , Shanghai, China , Tianjin, China , Wuhan, China , Xi’an, China and 2 more locations